Visceral leishmaniasis (VL) or kala-azar is a vector-borne dreaded protozoal infection that is
caused by the parasite Leishmania donovani. With increases in the dramatic infection rates …

Leishmaniasis is a complex protozoan infectious disease and, associated with malnutrition,
poor health services and unavailability of prophylactic control measures, neglected …

Background This study aimed to investigate compounds acting on the host cell machinery to
impair parasite installation with the possible advantage of limiting drug resistance. The …

Leishmaniasis affects over 150 million people all over the world, especially in subtropical
regions. Currently used antileishmanial synthesized drugs are associated with some …

Visceral leishmaniasis (VL) caused by the parasite Leishmania donovani, is a potentially
fatal disease. It is characterized by prolonged fever, enlarged spleen and liver, substantial …

To study the structure–activity relationship of coumarin (−) mammea A/BB isolated from the
CH2Cl2 extract of Calophyllum brasiliense leaves, we evaluated the antileishmanial activity …

The protozoan parasite Leishmania causes a spectrum of diseases and there are over 1
million infections each year. Current treatments are toxic, expensive, and difficult to …

CUTANEOUS LEISHMANIASIS is endemic in 88 different countries. There are an estimated
1.5 million new cases each year, with over 90% occurring in Afghanistan, Algeria, Iran, Iraq …

Leishmaniasis is an infectious disease caused by parasites belonging to the Leishmania
genus. This disease has a prevalence that exceeds 12 million, and approximately 350 …

Leishmaniasis, a vector-borne parasitic disease resulting from infection of macrophages by
obligate intracellular parasites of genus Leishmania, has been considered a major tropical …